Phase II Study of Allo LMI Vaccine With IL-2 for Stable Metastatic Breast Ca
Clinical trial NCT00784524 · TERMINATED
Trial details
- NCT number
- NCT00784524
- Sponsor
- Masonic Cancer Center, University of Minnesota
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-09-01
- Primary completion
- 2014-07-01
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.